Sexually transmitted infection

Infectious Disease Diagnostics Market, 2026

Retrieved on: 
Wednesday, July 31, 2019

Infectious disease IVD products include reagents, consumables, and instruments based primarily on immunoassays, molecular technologies, and conventional microbiology techniques.

Key Points: 
  • Infectious disease IVD products include reagents, consumables, and instruments based primarily on immunoassays, molecular technologies, and conventional microbiology techniques.
  • Data provided include the following:
    World Infectious Disease Diagnostic Test Market, 2018-2026 ($ millions)
    Global Infectious Disease IVD Demand by Product Group 2018 - 2026 (million dollars) (STDs, Hepatitis, HIV/AIDS, HAIs, ID/AST, Influenza, Tuberculosis, TORCH, Other, Total Demand)
    Global Sexually Transmitted Disease (STD) IVD Demand by Test Type & Condition 2018 - 2026 (million dollars) (By Type of Test: Immunoassay, Molecular, Other; By Condition: Chlamydia, HPV, Gonorrhea, Herpes HSV-2, Syphilis, Other; Global STD IVD Demand)
    Global Hepatitis IVD Demand by Test Type 2018 - 2026 (million dollars) (Laboratory Tests, Blood Screening, POC Tests, Global Hepatitis IVDs)
    Global HIV/AIDS IVD Demand by Test Type 2018 - 2026 (million dollars) (Laboratory Tests, Blood Screening, POC Tests, Global HIV/AIDS IVDs)
    Global Healthcare-Associated Infections (HAIs) IVD Demand by Test Type & Condition 2018 - 2026 (million dollars) (By Type of Test: Immunoassay, Molecular, Microbiology; By Condition: C. diff, Sepsis, MRSA, VRE, Other HAIs; Global HAIs IVDs)
    Identification/Antibiotic Susceptibility Testing (ID/AST) Demand by Test Type 2018 - 2026 (million dollars) (Automated Tests, Manual Tests, Global ID/AST)
    Global Influenza Testing IVD Demand by Test Type 2018 - 2026 (million dollars) (Rapid ID Tests, Molecular Tests, Other Tests, Global Influenza IVDs)
    Global Tuberculosis (TB) Testing IVD Demand by Test Type 2018 - 2026 (million dollars) (Microbiology Tests, POC Tests, Molecular Tests, Global Tuberculosis IVDs)
    Global Other Infectious Disease IVD Demand by Condition 2018 - 2026 (million dollars) (Malaria, Streptococcal Infections, Lyme Disease, Fungal Infections, Parasitic Conditions, RSV, Emerging Infections, Dengue Fever, All Other Conditions, Global Other Infection IVDs)
    The report also reviews various infectious disease testing technologies (immunoassay, microbiology, and molecular), markets (hospital and independent testing laboratories, POC and POL laboratories, blood banks, and other end-users), and products (reagents and consumables and instruments):
    Global Infectious Disease IVD Reagents, Consumables, & Instruments Demand 2018 - 2026 (million dollars) (Reagents/Consumables: STDs, Hepatitis, HIV/AIDS, HAIs, ID/AST, Influenza, Tuberculosis, TORCH-Related, Other; Instruments & Systems; Global infection IVDs)
    Global Infectious Disease IVD Demand by Technology 2018 - 2026 (million dollars) (Immunoassay, Molecular, Microbiology & Related, Global Infection IVDs)
    Global Infectious Disease IVD Demand by End-Use Market 2018 - 2026 (million dollars) (Hospitals, Clinical Laboratories, POC Laboratories, Other Markets, Global Infection IVDs)
    Based on a high level of national health expenditures and patient activity and the large role played by private medical providers in the healthcare system, the U.S. will remain the largest and most diversified infectious disease testing market.
  • The report looks at market drivers, including external market influences that are promoting the development and use of improved infectious disease diagnostics.
  • The report details the major competitors that are global market leaders in infectious disease testing products and technologies, including an overview and an outline of these company's infectious disease IVD products:

Global Sexually Transmitted Disease (STD) Testing (Test Services, Diagnostics) Markets Report 2019: Focus on Chlamydia, Gonorrhea, Syphilis, HPV, HIV, HSV, TV

Retrieved on: 
Friday, July 26, 2019

The market for STD diagnostic systems and tests is being driven by efforts worldwide that aim to screen, diagnose, and treat STD infections.

Key Points: 
  • The market for STD diagnostic systems and tests is being driven by efforts worldwide that aim to screen, diagnose, and treat STD infections.
  • To improve the STD landscape, healthcare systems globally have initiated national screening and also incentivized voluntary screening.
  • Sexually Transmitted Disease (STD) Testing Markets examines the diagnostics market for different STDs based on key individual country and regional markets.
  • Laboratory-based testing for STDs currently holds a greater share of the STD diagnostics market.

Sexually Transmitted Disease (STD) Testing (Test Services, Diagnostics) Markets, 2023 - ResearchAndMarkets.com

Retrieved on: 
Friday, July 26, 2019

The market for STD diagnostic systems and tests is being driven by efforts worldwide that aim to screen, diagnose, and treat STD infections.

Key Points: 
  • The market for STD diagnostic systems and tests is being driven by efforts worldwide that aim to screen, diagnose, and treat STD infections.
  • To improve the STD landscape, healthcare systems globally have initiated national screening and also incentivized voluntary screening.
  • Sexually Transmitted Disease (STD) Testing Markets examines the diagnostics market for different STDs based on key individual country and regional markets.
  • Laboratory-based testing for STDs currently holds a greater share of the STD diagnostics market.

Global Sexually Transmitted Disease (STD) Testing Market 2019-2023 | 9% CAGR Projection over the Next Five Years | Technavio

Retrieved on: 
Friday, July 26, 2019

The global sexually transmitted disease (STD) testing market is expected to post a CAGR of close to 9% during the period 2019-2023, according to the latest market research report by Technavio .

Key Points: 
  • The global sexually transmitted disease (STD) testing market is expected to post a CAGR of close to 9% during the period 2019-2023, according to the latest market research report by Technavio .
  • View the full release here: https://www.businesswire.com/news/home/20190726005101/en/
    Technavio has announced its latest market research report titled global sexually transmitted disease (STD) testing market 2019-2023 (Graphic: Business Wire)
    A key factor driving the growth of the global sexually transmitted disease (STD) testing market size is the increased initiatives by governments worldwide.
  • This global sexually transmitted disease (STD) testing market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.
  • Global Sexually Transmitted Disease (STD) Testing Market: Segmentation Analysis
    This market research report segments the global sexually transmitted disease (STD) testing market by product (laboratory testing devices, and POC testing devices), and geographic regions (North America, Europe, Asia, and ROW).

/R E P E A T -- Government of Canada Launches Action Plan on Sexually Transmitted and Blood-Borne Infections/

Retrieved on: 
Thursday, July 18, 2019

However, we are seeing a resurgence of sexually transmitted infections in Canada.

Key Points: 
  • However, we are seeing a resurgence of sexually transmitted infections in Canada.
  • This is occurring despite our having the knowledge and tools to prevent, treat and, in many cases, cure sexually transmitted and blood-borne infections (STBBI).
  • The Action Plan will draw on our strengths and leadership as we work with our partners to make a difference for Canadians."
  • The Action Plan recognizes that STBBI do not affect all people equally because of differing social, economic and other factors.

Government of Canada Launches Action Plan on Sexually Transmitted and Blood-Borne Infections

Retrieved on: 
Thursday, July 18, 2019

However, we are seeing a resurgence of sexually transmitted infections in Canada.

Key Points: 
  • However, we are seeing a resurgence of sexually transmitted infections in Canada.
  • This is occurring despite our having the knowledge and tools to prevent, treat and, in many cases, cure sexually transmitted and blood-borne infections (STBBI).
  • This follows the 2018 release of the Pan-Canadian Sexually Transmitted and Blood-Borne Infections Framework for Action , which provides a roadmap:
    for collaborative and complementary actions to reduce the impact of STBBI in Canada, and
    to contribute to the global efforts to end AIDS, viral hepatitis, and sexually transmitted infections as major health concerns.
  • This Action Plan, which takes a whole-of-government approach to addressing these infections, will help us reach our global goal of ending AIDS, viral hepatitis and sexually transmitted infections as public health threats by 2030."

Consumer Advocacy Group, Responsible Telemedicine, Sues WebMD for False Advertising, Withholding of Material Information and Violation of Patient Trust

Retrieved on: 
Tuesday, July 16, 2019

WebMD claims that all of their diagnostic tests are approved by the United States Food and Drug Administration (FDA).

Key Points: 
  • WebMD claims that all of their diagnostic tests are approved by the United States Food and Drug Administration (FDA).
  • These nine tests include tests for chlamydia, gonorrhea, hepatitis B, hepatitis C, syphilis, herpes 1, herpes 2 , HIV and trichomoniasis.
  • When a well-respected source in the medical field, like WebMD, breaks patients' trust, quick and swift action must be taken.
  • "It is Responsible Telemedicine's hope that we can create a future of transparency and trust in digital healthcare.

UMN Medical School Report Shows Sexually Transmitted Infections at All-Time High Among MN Youth

Retrieved on: 
Tuesday, June 18, 2019

MINNEAPOLIS, June 18, 2019 /PRNewswire/ -- While pregnancy and birth rates continue to decline for 15 to 19-year-olds, putting them at historic lows, Minnesota youth are contracting sexually transmitted infections (STI) at alarmingly high rates.

Key Points: 
  • MINNEAPOLIS, June 18, 2019 /PRNewswire/ -- While pregnancy and birth rates continue to decline for 15 to 19-year-olds, putting them at historic lows, Minnesota youth are contracting sexually transmitted infections (STI) at alarmingly high rates.
  • The HYD-PRC's report notes that Minnesota youth are disproportionately impacted by sexually transmitted infections.
  • Birth rates for American Indian, black, and Latinx youth are higher than for white youth.
  • The University of Minnesota Medical School is at the forefront of learning and discovery, transforming medical care and educating the next generation of physicians.

Asia-Pacific Infectious Disease Point-of-Care Testing 2019-2023: Rising Prevalence of TB, HIV, and Hepatitis, Accompanied by the Development of Portable POCT Devices

Retrieved on: 
Monday, June 17, 2019

This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market.

Key Points: 
  • This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market.
  • The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests.
  • The Asia-Pacific shows the highest prevalence of infectious diseases, such as tuberculosis (TB), hepatitis, and sexually transmitted infections (STIs).
  • With the rising disease prevalence, companies are shifting their business models to a more consumer-oriented approach.

Growth Insights in APAC Infectious Disease Point-of-Care Testing (POCT) Market - Forecast to 2023 - ResearchAndMarkets.com

Retrieved on: 
Monday, June 17, 2019

The "Growth Insights in APAC Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Growth Insights in APAC Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
  • This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market.
  • The Asia-Pacific shows the highest prevalence of infectious diseases, such as tuberculosis (TB), hepatitis, and sexually transmitted infections (STIs).
  • Additionally, it gives an insight on the leading market trends shaping the industry and their long-term implications on market growth.